CLNN
Price
$3.67
Change
+$0.01 (+0.27%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
32.97M
KYMR
Price
$40.84
Change
-$2.13 (-4.96%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
2.87B
4 days until earnings call
Interact to see
Advertisement

CLNN vs KYMR

Header iconCLNN vs KYMR Comparison
Open Charts CLNN vs KYMRBanner chart's image
Clene
Price$3.67
Change+$0.01 (+0.27%)
Volume$285
Capitalization32.97M
Kymera Therapeutics
Price$40.84
Change-$2.13 (-4.96%)
Volume$8.42K
Capitalization2.87B
CLNN vs KYMR Comparison Chart in %
Loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLNN vs. KYMR commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNN is a Buy and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CLNN: $3.66 vs. KYMR: $41.35)
Brand notoriety: CLNN and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLNN: 28% vs. KYMR: 61%
Market capitalization -- CLNN: $32.97M vs. KYMR: $2.87B
CLNN [@Biotechnology] is valued at $32.97M. KYMR’s [@Biotechnology] market capitalization is $2.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLNN’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CLNN’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than CLNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLNN’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • CLNN’s TA Score: 5 bullish, 5 bearish.
  • KYMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CLNN and KYMR are a good buy in the short-term.

Price Growth

CLNN (@Biotechnology) experienced а +4.87% price change this week, while KYMR (@Biotechnology) price change was -6.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.87B) has a higher market cap than CLNN($33M). KYMR YTD gains are higher at: 2.784 vs. CLNN (-31.073). CLNN has higher annual earnings (EBITDA): -24.01M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. CLNN (9.83M). CLNN has less debt than KYMR: CLNN (20.9M) vs KYMR (86.3M). KYMR has higher revenues than CLNN: KYMR (58.9M) vs CLNN (350K).
CLNNKYMRCLNN / KYMR
Capitalization33M2.87B1%
EBITDA-24.01M-232.67M10%
Gain YTD-31.0732.784-1,116%
P/E RatioN/AN/A-
Revenue350K58.9M1%
Total Cash9.83M463M2%
Total Debt20.9M86.3M24%
FUNDAMENTALS RATINGS
CLNN: Fundamental Ratings
CLNN
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLNNKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX43.090.28
+0.65%
American Funds Intl Gr and Inc F3
ARTNX17.260.08
+0.47%
Artisan Select Equity Investor
TACLX19.67N/A
N/A
Touchstone Large Cap A
OPMSX30.29N/A
N/A
Invesco Main Street Mid Cap A
FHJTX43.44N/A
N/A
Fidelity Advisor Europe C

CLNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLNN has been loosely correlated with LYRA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CLNN jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
-0.81%
LYRA - CLNN
40%
Loosely correlated
+0.44%
KYMR - CLNN
36%
Loosely correlated
-3.77%
VERA - CLNN
35%
Loosely correlated
-6.73%
KZIA - CLNN
33%
Poorly correlated
-0.12%
GOSS - CLNN
30%
Poorly correlated
-8.33%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-3.77%
NRIX - KYMR
67%
Closely correlated
-7.52%
VERA - KYMR
59%
Loosely correlated
-6.73%
CGON - KYMR
56%
Loosely correlated
-6.12%
LYRA - KYMR
54%
Loosely correlated
+0.44%
IDYA - KYMR
53%
Loosely correlated
-2.03%
More